Patent Row

  • Relief for Pfizer on anti-cancer drug 04-06-2013 09:11 PM

    Chennai: In a relief to pharma major Pfizer, the Intellectual Property Appellate Board in Chennai has set aside the revocation of the patent of the company's anti-cancer drug 'Sutent'. The Board has asked the Patent Office to consider the entire matter afresh in a time-bound manner, which had twice revoked...
  • Patent row: HC refuses interim relief to Merck 05-04-2013 05:54 PM

    New Delhi: The Delhi High Court on Friday refused to grant interim relief on a patent row to US pharmaceuticals major Merck Sharp and Dohme (MSD) which sought a restraint on Indian firm Glenmark Pharmaceuticals manufacturing and marketing anti-diabetes drugs Zita and Zita-Met. Justice Rajiv Sahai Endlaw dismissed the interim...
  • 'Has to be a balance between innovation, affordability of drugs' 01-04-2013 03:37 PM

    The Supreme Court on Monday dismissed Swiss pharma company Novartis' plea for a patent on its drug cancer drug Glivec. ...